Rivaroxaban for Treatment of Left Ventricular Thrombus: A Case Report: A case report

Juhaina Salim Al-Maqbali, Maitha Al-Sibani, Nasiba Al-Maqrashi, Abdullah M. Al Alawi*, Hatim Al Lawati

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

1 اقتباس (Scopus)

ملخص

Objective: Background: Case Report: Conclusions: Unusual clinical course Left ventricular thrombus (LVT) is a complication of left ventricular dysfunction and myocardial infarction (MI) and is associated with systemic thromboembolism. Two-dimensional transthoracic echocardiography (TTE) is considered the first-line diagnostic tool for detection of LVT. Vitamin K antagonists (VKA) targeting an international normalized ratio (INR) from 2 to 3 are the only approved treatments by the Food and Drug Administration (FDA). New emerging observational data support the use of direct oral anticoagulants (DOACs) as an alternative therapeutic option; however, their safety and efficacy have not been assessed in a good-quality randomized controlled trial. Here, we present a case of a 43-year-old man diagnosed with human immunodeficiency virus (HIV)-associated dilated cardiomyopathy complicated with an LVT. He was treated with rivaroxaban for 9 consecutive months with no interruption of therapy at any point in time; however, he presented to the emergency department with symptoms of decompensated heart failure. A follow-up TTE demonstrated a significant increase in the size of his LVT. This case questions the efficacy of using factor Xa inhibitor (rivaroxaban) as an alternative option for LVT treatment. This case demonstrates a failure of rivaroxaban in treating LVT in a patient with HIV-associated dilated cardiomyopathy. Good-quality randomized clinical trials or prospective studies are required to establish the efficacy and safety of DOACs for LVT treatment as an alternative to VKA.

اللغة الأصليةEnglish
رقم المقالdoi: 10.12659/AJCR.932140. PMID: 34168105; PMCID: PMC8245028.
دوريةAmerican Journal of Case Reports
مستوى الصوت22
رقم الإصدار1
المعرِّفات الرقمية للأشياء
حالة النشرPublished - يونيو 25 2021

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2700???

قم بذكر هذا